IXICO plc (FRA:PYPB)

Market Cap	7.48M -11.5%
Revenue (ttm)	7.49M +13.3%
Net Income	-1.89M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0715
Previous Close	0.0715
Day's Range	0.0715 - 0.0715
52-Week Range	0.0705 - 0.1530
Beta	n/a
RSI	30.93
Earnings Date	May 19, 2026

About IXICO

IXICO plc provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally. The company offers collection, analysis, management, and reporting on gathered clinical study data; neurological diseases data collection and analysis; and sales and marketing services. It also provides imaging contract research organization solutions, including imaging biomarkers, such as radiological reads, volumetric MRI, PET and SPECT, and advanced MRI...

• Industry: Medicinal Chemicals and Botanical Products
• CEO: Bram Goorden
• Employees: 79
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PYPB

Financial Performance

In fiscal year 2025, IXICO's revenue was 6.53 million, an increase of 13.32% compared to the previous year's 5.77 million. Losses were -1.65 million, -17.49% less than in 2024.

Financial numbers in GBP